Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Nanomedicine in GI.

Hamed Laroui¹, David S Wilson, Guillaume Dalmasso

¹Department of Medicine, Division of Digestive Diseases, Emory University School of Medicine, Atlanta, GA 30322, USA.

American Journal of Physiology. Gastrointestinal and Liver Physiology

|December 15, 2010

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Oral Colon-Targeted Lipid Nanoparticles Enhance Upadacitinib Delivery and Efficacy in a Murine Model of Ulcerative Colitis.

International journal of molecular sciences·2026

Same author

Leader cell myosin 10 controls adhesion dynamics, invasion, and EMT pathway activation.

Cell communication and signaling : CCS·2026

Same author

Monitoring Biomolecular Changes During Colitis Progression Using Infrared Spectroscopy in Dextran Sodium Sulfate-Treated Mouse Serum.

Journal of biophotonics·2026

Same author

Programming DNA machines to move.

Nature reviews. Chemistry·2026

Same author

DNA Motors Powered by Exonuclease III for Autonomous Rolling Motion and Biosensing Applications.

bioRxiv : the preprint server for biology·2025

Same author

Cytotoxic necrotizing factor 1-producing E. coli enhance colorectal tumorigenesis in ApcMin/+ mice with autophagy deficiency in intestinal epithelial cells.

The Journal of infectious diseases·2025

Same journal

MYO5B Deficiency Is Associated with Altered MUC13 Localization and DMBT1 Accumulation in Intestinal Epithelial Cells.

American journal of physiology. Gastrointestinal and liver physiology·2026

Same journal

Microbiota dysbiosis and mucosal hyperinnervation contribute to intestinal hyperalgesia in a mouse model of post-infectious irritable bowel syndrome.

American journal of physiology. Gastrointestinal and liver physiology·2026

Same journal

Roux-en-Y gastric bypass alters microbial circadian rhythms with links to metabolic improvement.

American journal of physiology. Gastrointestinal and liver physiology·2026

Same journal

Therapeutic zinc targets dysregulated GC-C signaling and restores ileal defects in a preclinical model of familial diarrheal disease.

American journal of physiology. Gastrointestinal and liver physiology·2026

Same journal

Epithelial fucosylation regulates intestinal stem cell differentiation.

American journal of physiology. Gastrointestinal and liver physiology·2026

Same journal

Claims regarding the fidelity of extracellular electrical recording from gastrointestinal muscles not validated suitably.

American journal of physiology. Gastrointestinal and liver physiology·2026

See all related articles

Nanotechnology advances offer new hope for gastrointestinal disease detection and treatment. Nanoparticle drug delivery systems promise targeted therapies with reduced side effects, improving patient outcomes.

Area of Science:

Nanotechnology
Nanomedicine
Gastrointestinal Diseases

Background:

Nanotechnology offers novel approaches for disease management.
Nanomedicine is emerging as a key area for targeted therapies.
Gastrointestinal diseases require innovative treatment strategies.

Purpose of the Study:

To review recent nanomaterial applications in gastrointestinal disease detection.
To explore the potential of nanotechnology in treating gastrointestinal disorders.
To integrate current knowledge on nanomedicine for gastrointestinal applications.

Main Methods:

Literature review of recent advancements in nanotechnology for gastrointestinal diseases.
Analysis of nanoparticle-based drug delivery systems.

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Related Experiment Videos

Last Updated: Jun 6, 2026

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Integration of studies on nanomaterial applications for disease detection and treatment.

Main Results:

Nanoparticle vectors enable targeted drug delivery to affected gastrointestinal regions.
Prolonged drug release from nanoparticles can enhance treatment efficacy.
Nanomaterials show significant potential for early disease detection and intervention.

Conclusions:

Nanotechnology-driven nanomedicine presents a promising future for gastrointestinal disease management.
Targeted nanoparticle delivery can minimize side effects of current treatments.
Further research into novel nanomaterials will advance gastrointestinal healthcare.